What Is KALA BIO, Inc. (KALA) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, KALA BIO, Inc.'s intrinsic value is estimated at $2.30, suggesting a +123.4% average upside from the current price of $1.03. While 5 models see room for appreciation, model agreement is not unanimous as 1 model flags potential overvaluation. Model dispersion is worth noting: Dynamic NAV targets $4.24 (+311.9%), versus Bayesian DCF at $0.06 (-94.1%). This +406.0% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About KALA?
7 of 13 models are currently active for KALA. Of these, 5 models suggest upside while 2 models suggest overvaluation. The Bayesian DCF estimates KALA's intrinsic value at $0.06, implying -94.1% downside from the current price. See which stocks rank higher →
How Does KALA Rank in Pharmaceutical Preparations?
Among 431 Pharmaceutical Preparations stocks, KALA ranks #389 by Quality of Company score. CirclFi's QOC score of 2.9/10 evaluates 32 fundamental signals. A score of 2.9 signals below-average fundamentals.
See all Most Undervalued Pharmaceutical Preparations Stocks →
As a biopharma enterprise, KALA BIO, Inc. operates in a sector where R&D productivity ratio is a critical driver of valuation. Investors evaluating KALA should weigh these sector-specific dynamics alongside our model-derived fair values.
Is KALA a Value Trap?
CirclFi's Value Trap algorithm assigns KALA a score of 39/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
7 of 13 models are active for KALA BIO, Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, KALA BIO, Inc.'s fundamental quality profile registers 2.9/10. This concerning score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +406.0% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every KALA valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across KALA's 7 active models, average confidence is 23%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad